Tonix in the News

Nature Biotechnology | Sep 9, 2022

Monkeypox response relies on three vaccine suppliers

Endpoints News | Aug 24, 2022

'Nothing escapes our scientists': A handful of biotechs gear up work on monkeypox

The Frederick News-Post | Aug 18, 2022

Tonix Pharmaceuticals develops monkeypox vaccine for future by looking at past

BioProcess International | Aug 16, 2022

Tonix looks to live virus vaccines to prevent the spread of monkeypox

Proactive | Aug 11, 2022

Tonix Pharmaceuticals prepares to tackle monkeypox outbreak with TNX-801 vaccine

Benzinga | Jul 25, 2022

EXCLUSIVE: Tonix Pharmaceuticals CEO Highlights Advantages Of Company's Monkeypox Vaccine In Development

New Bedford Guide | Jun 22, 2022

Tonix Pharmaceuticals facility officially opens in the New Bedford Business Park

BioCentury | Jun 14, 2022

Poxvirus agents, by the mechanisms

The New York Times | Jun 3, 2022

21 Americans Infected With Monkeypox, C.D.C. Reports

Bioprocess Online | May 31, 2022

What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D. (Podcast)

Proactive | May 25, 2022

Tonix Pharmaceuticals Talks Through its 1Q 2022 Financial and Operational Highlights

Benzinga | May 5, 2022

At Tonix, History Underpins a Modern Approach to COVID-19 Vaccines

Bloomberg | May 2, 2022

Balance of Power: Omicron Subvariant Raises Concerns (Podcast)

Benzinga | Apr 7, 2022

Tonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients

FiercePharma | Mar 8, 2022

Mass General plans study of nasally delivered binge eating disorder drug

Clinical Trials Arena | Feb 8, 2022

Long Covid-19: Tonix reveals Phase II trial design plans

Benzinga | Feb 1, 2022

Could This Be A Potential New Weapon In The Fight Against COVID-19?

HCP Live | Nov 6, 2021

Daily Sublingual Cyclobenzaprine Improves Sleep, Pain Outcomes in Fibromyalgia Patients

Maryland.gov | Oct 20, 2021

Tonix Pharmaceuticals expands into Frederick, Md.

The Frederick News-Post | Oct 18, 2021

Tonix is enrolling participants in a Phase 3 trial for fibromyalgia, the RESILIENT study. For more information, please visit www.resilientstudy.com or www.clinicaltrials.gov (NCT05273749).

Tonix in the News

Monkeypox response relies on three vaccine suppliers

'Nothing escapes our scientists': A handful of biotechs gear up work on monkeypox

Tonix Pharmaceuticals develops monkeypox vaccine for future by looking at past

Tonix looks to live virus vaccines to prevent the spread of monkeypox

Tonix Pharmaceuticals prepares to tackle monkeypox outbreak with TNX-801 vaccine

EXCLUSIVE: Tonix Pharmaceuticals CEO Highlights Advantages Of Company's Monkeypox Vaccine In Development

Tonix Pharmaceuticals facility officially opens in the New Bedford Business Park

Poxvirus agents, by the mechanisms

21 Americans Infected With Monkeypox, C.D.C. Reports

What's Next For COVID Vaccines With Tonix Pharmaceuticals' Seth Lederman, M.D. (Podcast)

Tonix Pharmaceuticals Talks Through its 1Q 2022 Financial and Operational Highlights

At Tonix, History Underpins a Modern Approach to COVID-19 Vaccines

Balance of Power: Omicron Subvariant Raises Concerns (Podcast)

Tonix Pharma Starts New Pivotal Trial For TNX-102 SL In Fibromyalgia Patients

Mass General plans study of nasally delivered binge eating disorder drug

Long Covid-19: Tonix reveals Phase II trial design plans

Could This Be A Potential New Weapon In The Fight Against COVID-19?

Daily Sublingual Cyclobenzaprine Improves Sleep, Pain Outcomes in Fibromyalgia Patients

Tonix Pharmaceuticals expands into Frederick, Md.

New Infectious Disease Research and Development Center Opens in Frederick